Navigation Links
EDETEK Expands Leadership Team - Tom Guinter joins as Vice President, Product Services; Mark Gee joins as Senior Director, Product Business Development
Date:6/19/2017

As Vice President, Product Services, Mr. Guinter is responsible for overseeing all service activities supporting EDETEK’s products including training, implementation, support, and client process and SOP development.

Mr. Guinter brings a wealth of industry experience to his new role. He has previously held leadership roles for service providers and top-tier pharmaceuticals, and as an independent consultant supported a top-tier biotech development of their standardization processes ground-up. Mr. Guinter has been a volunteer to CDISC since 2001, was a co-lead for the CDISC Submission Data Standards team when the Study Data Tabulation Model (SDTM) was developed and is an acknowledged principle contributor to the SDTM.

As Senior Director, Product Business Development, Mr. Gee is responsible for introducing EDETEK products to potential clients, managing existing client relationships, forming partnerships with key target pharma companies, and managing the full sales cycle

Mr. Gee brings over 15 years of pharma industry business development expertise to EDETEK. His experience working with numerous technology based companies, whose products and services significantly improved the entire clinical trial process, will be of significant value to EDETEK.

Jian Chen, EDETEK’s President and CEO, commented, “Tom and Mark both bring a wealth of experience to our leadership team. It is an exciting time when top industry talent is recognizing, and joining our EDETEK teams to provide unmatched products and services to the entire life science industry.”

Tom Guinter, Vice President, Product Services, added, “I am excited to join the EDETEK teams, everything I saw and see at EDETEK convinced me this is the most dynamic team in industry, completely committed to making a difference in the flow of information throughout the clinical research lifecycle.”

Mark Gee, Senior Director, Product Business Development, added, “At this point in my career I was looking to join forces with a company whose technology and services have the potential, from an innovative perspective, to positively change how clinical trial data is managed and utilized. EDETEK was a perfect fit. After evaluating EDETEK’s current technologies and their extensive product development program I am excited about the future EDETEK has and I am honored to be an integral part of it."

Mr. Guinter and Mr. Gee are located in EDETEK’s headquarters office in Princeton, NJ

About EDETEK

EDETEK, Inc., a CDISC Registered Solutions Provider and AWS Life Sciences Partner is a technology provider to biopharmaceutical and medical device companies. Founded in 2009, EDETEK now has global presence in US, Europe, and China, providing SaaS based clinical technologies that manage the entire lifecycle of clinical information.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14437078.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. EDETEK Unveils New CONFORM™ Products at DIA 2017 Annual Meeting
2. Assured Enterprises Expands its Digital Security Platform, Partnering with Qafis Ltd, TeeBase UK Ltd. and C3 Security Inc.
3. RoviSys Expands Parsec Partnership, Broadens Options for Real-Time Data Solutions
4. Stratevi Expands to East Coast with Boston Office Opening
5. Cirrascale Cloud Services Expands Deep Learning Development Offerings with Support for NVIDIA Quadro GP100
6. The Scripps Research Institute (TSRI) Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle
7. Leading Family Genomics Company Good Start Genetics Expands Payor Relationships to More than 130 Million Covered Lives
8. Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
9. FireflySci USA Expands Spectrophotometer Calibration Standard Network to Canada
10. BellBrook Labs Expands Drug Discovery Services Portfolio to Include Lead Discovery Services
11. Genedata Expands Into United Kingdom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2018)... LINDA, Calif. (PRWEB) , ... October 02, 2018 ... ... labs. Undetected or ignored, contamination endangers the reliability and reproducibility of experimental data. ... microbial contamination. , In this educational webinar, which is sponsored by Eppendorf ...
(Date:9/27/2018)... ... September 26, 2018 , ... NDA ... Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more ... industry has joined the firm as an Expert Consultant. Her experience includes leadership ...
(Date:9/27/2018)... ... September 27, 2018 , ... ... MA, announce today that Holotype HLA and other Omixon products will be featured ... the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s ...
(Date:9/15/2018)... LINDA, Calif. (PRWEB) , ... September 14, 2018 , ... ... treat patients. But even with new technologies, challenges remain. In the past, the sheer ... , St. Jude Cloud is a new data ecosystem developed to advance cures ...
Breaking Biology Technology:
(Date:10/1/2018)... ... 2018 , ... NanoValent Pharmaceuticals, Inc ., (NanoValent) a ... today announced the National Institute of Health (NIH) Small Business ... for two separate grants. These two grants will allow NanoValent to advance two ...
(Date:10/1/2018)... , ... October 01, 2018 , ... Paragon Biosciences CEO Jeff Aronin was ... sector and for his work bringing life-altering drugs to patients in need. Jeff’s vision has ... Approvals earned by the R&D teams now at Paragon and its portfolio companies. ...
(Date:10/1/2018)... SAN FRANCISCO (PRWEB) , ... October 01, 2018 ... ... for about 2.13 million of the nation’s elderly, stories surrounding such facilities ... the nation’s largest assisted living provider, which alleges that the chain’s “callous and ...
Breaking Biology News(10 mins):